Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Epothilone in Recurrent Glioblastoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
URINARY VEGF Levels in GBM Patients on Radiation Treatment Protocol
- Status
- UNKNOWN
- Phase
- N/A
The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)
- Status
- COMPLETED
- Phase
- PHASE2
PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)
- Status
- COMPLETED
- Phase
- PHASE3
Enzastaurin Versus Lomustine in Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE3
Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)
- Status
- TERMINATED
- Phase
- PHASE2
Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2